tirzepatide release date When Is the Best Time to Start Tirzepatide: Clinical Guidance The weight-loss drug that melts

Statistical analysis Data are presented as means SD

PubMed Clinical review on high-protein diets and kidney function

CME INDIA Clinical Pearls Retatrutide may redefine obesity pharmacotherapy by crossing the 2530% weight-loss threshold, but clinicians must remember that efficacy does not replace the need for careful patient selection, titration, adverse-event monitoring, nutritional surveillance and long-term maintenance strategy

These findings suggest that incretin-based therapies may confer favorable lipid effects in routine clinical practice, although the magnitude of benefit may vary across agents

Plasma remnant lipoprotein cholesterol is also significantly reduced 4 h post-meal in these patients (Schwartz et al., 2010)